Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW677954 in Combination With Insulin for Type 2 Diabetes Mellitus
NCT00437164Phase 2Terminated
- Sponsor
- GSK
- Start
- Sep 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saroglitazar in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Sep 2006; status: terminated.
02
Drugs
saroglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00437164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437164.